Nicholas Graves

Duke-NUS Medical School

Papers

1

Total Citations

47

H-Index

1

About

Nicholas Graves is a leading health economist whose research focuses on the economic evaluation of infection control, antimicrobial stewardship, and surgical interventions. His major contributions include pioneering cost-effectiveness analyses of hospital-based infection prevention strategies, particularly for surgical site infections and antimicrobial resistance. With over 47 citations on his landmark ENDO-3 trial—a phase III randomized study comparing sentinel node biopsy to no retroperitoneal node dissection in early-stage endometrial cancer—Graves has shaped clinical guidelines by demonstrating that less invasive approaches can reduce costs without compromising outcomes. His work extends to modeling the economic burden of healthcare-associated infections and evaluating the value of rapid diagnostic tests. Graves’ research is widely cited for its rigorous methodology and practical implications, influencing policy in Australia and globally. He has also contributed to the development of decision-analytic models for resource allocation in infectious disease control, earning recognition as a key figure in health economics.

Research Focus

Key Achievements

1
H-Index
1
Papers
47
Total Citations
47
Avg Citations/Paper
🏆 Most Cited Paper
A phase III randomized clinical trial comparing sentinel node biopsy with no retroperitoneal node dissection in apparent early-stage endometrial cancer – ENDO-3: ANZGOG trial 1911/2020
47 citations · 2021
📈 Most Prolific Year: 2021 (1 Papers)
🤝 Key Collaborators: 11
🏛 Institutions: Duke-NUS Medical School

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago